JVMRX | NQVAX | JVMRX / NQVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 22 years | - |
Gain YTD | 3.786 | 3.379 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.1B | 508M | 4,547% |
Annual Yield % from dividends | 0.93 | 0.98 | 96% |
Returns for 1 year | 5.82 | 24.66 | 24% |
Returns for 3 years | 1.65 | 38.38 | 4% |
Returns for 5 years | 26.86 | 78.04 | 34% |
Returns for 10 years | 49.19 | 153.26 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MLRSX | 12.35 | 0.13 | +1.06% |
NYLI Winslow Large Cap Growth Class R6 | |||
SDGZX | 124.65 | 1.16 | +0.94% |
DWS Capital Growth R6 | |||
SGMIX | 9.85 | 0.04 | +0.41% |
SEI Global Managed Volatility I (SIMT) | |||
EMAAX | 14.81 | 0.05 | +0.34% |
Gabelli Entpr Mergers & Acquisitions A | |||
PVCMX | 12.22 | -0.01 | -0.08% |
Palm Valley Capital Investor |